55
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Usual Opioid Dosing Does Not Adversely Affect the Course of Healthcare-Associated Clostridioides Difficile Infection

, , , , , , , , , , , & ORCID Icon show all
Pages 151-157 | Received 14 Aug 2020, Accepted 18 Nov 2020, Published online: 22 Dec 2020

References

  • Magill SS , O’LearyE , JanelleSJet al. Changes in the prevalence of health-care associated infections in US hospitals. N. Engl. J. Med.379, 1732–1744 (2018).
  • Evans CT , SafdarN. Current trends in the epidemiology and outcomes of Clostridium difficile infection. Clin. Infect. Dis.60(S2), S66–S71 (2015).
  • Lessa FC , MuY , BambergWMet al. Burden of Clostridium difficile infection in the United States. N. Engl. J. Med.372, 825–834 (2015).
  • Zhang S , Palazuelos-MunozBalsells EMet al. Cost of hospital management of Clostridium difficile infection in United States – a meta-analysis and modelling study. BMJ Infect. Dis.16, 447 (2016).
  • Eze P , BallsellsE , KyawNair H. Risk factors for Clostridium difficile infections – an overview of the evidence and challenges in data synthesis. J. Glob. Health1, 010417 (2017).
  • Poirier D , GervaisP , FuchsMet al. Predictors of Clostridioides difficile infection among asymptomatic colonized patients: a retrospective cohort study. Clin. Infect. Dis.70, 2103–2210 (2020).
  • Loo VG , PoirierL , MillerMAet al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N. Engl. J. Med.353(23), 2442–2449 (2005).
  • Goorhuis A , BakkerD , CorverJet al. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin. Infect. Dis.47, 1162–1170 (2008).
  • Wang F , RoyS. Gut homeostasis, microbial dysbiosis, and opioids. Toxicol. Pathol.45, 150–156 (2017).
  • Banergee S , SindbergG , WangFet al. Opioid induced gut disruption and bile dysregulation leads to gut barrier compromise and sustained systemic inflammation. Mucosal Immunol.9(6), 1418–1428 (2016).
  • Dowell D , HaegerichTM , ChouRet al. CDC guideline for prescribing opioids for chronic pain – United States. JAMA315, 1624–1625 (2016).
  • Hardt C , BernsT , TrederW , DumoulinFL. Univariate and multivariate analysis of risk factors for severe Clostridium difficile-associated diarrhea: importance of co-morbidity and C-reactive protein. World J. Gastroenterol.14, 4338–4331 (2008).
  • Shivashankar R , KhannaS , KammerPPet al. Clinical factors associated with the development of severe-complicated Clostridium difficile infection. Clin. Gastroenterol. Hepatol.11, 1466–1471 (2013).
  • Mora A , SalazarM , Pablo-CaeiroJet al. Moderate to high use of opioid analgesics are associated with and increased risk of Clostridium difficile infection. Am. J. Med. Sci.343(4), 277–280 (2012).
  • Chakra A , PepinJ , ValiquetteL. Prediction tools for unfavorable outcomes in Clostridium difficile infection: a systematic review. PLoS ONE7(1), e30258 (2012).
  • McDonald LC , GerdingDN , JohnsonSet al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Disease Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin. Infect. Dis.66(7), E1–E48 (2018).
  • Surawicz CM , BrandtLJ , BinionDGet al. Guidelines for the diagnosis, treatment, and prevention of Clostridium difficile infections. Am. J. Gastroenterol.108, 478–498 (2013).
  • CDC dosing guidelines. Module 6: Module 6: dosing and titration of opioids. www.cdc.gov/drugoverdose/training/dosing/accessible/index.html
  • Korff MV , SaundersK , ThomasRG. De facto long term opioid therapy for noncancer pain. Clin J Pain. 24, 521–7 ( 2008).
  • Denawa Y , KurtzW , ConermannT. The social and functional implications of high- versus low-dose opioids in chronic non-cancer pain. Pain Physician22, 401–411 (2019).
  • Lewis PO , LitchfieldJM , TharpJLet al. Risk and severity of hospital acquired Clostridium difficile infection in patients taking proton pump inhibitors. Pharmacotherapy36, 986–993 (2016).
  • American Medical Association Opioid Task Force 2018 Progress Report. www.aafp.org/news/health-of-the-public/20180606amaopioidtaskforce.html
  • Guy G , ZhangK. Opioid prescribing by volume and specialty in the US. Am. J. Prev. Med.55, e153–e155 (2018).
  • Herzig SJ , RothbergMD , CheungMet al. Opioid utilization and opioid-related adverse events in non-surgical patients in US hospitals. J. Hosp. Med.9, 73–81 (2014).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.